Galectin Therapeutics Inc (GALT)

3.34 -0.03 (-0.89%) USD  |  NASDAQ  |  May 03, 16:00
3.36 +0.02 (+0.60%) After-Hours: 20:00
More

Galectin Therapeutics EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Fiscal Year Data

View and export this data back to 2021. Upgrade now.
Date Value
August 17, 2021 --
May 18, 2021 --
Date Value
April 16, 2021 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

Upgrade
Minimum
Apr 16 2021
Upgrade
Maximum
Aug 17 2021
Upgrade
Average
Upgrade
Median
May 18 2021

EPS Estimates for Current Fiscal Year Benchmarks

Madrigal Pharmaceuticals Inc Upgrade
Viking Therapeutics Inc Upgrade
89bio Inc Upgrade
Terns Pharmaceuticals Inc Upgrade
Enanta Pharmaceuticals Inc Upgrade

EPS Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade